coenzyme a has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunningham, RP; Diaz-Arias, A; Ganga, RR; Hammoud, GM; Ibdah, JA; Johnson, SA; Meers, GM; Moore, MP; Parks, EJ; Pitt, JB; Rector, RS; Spencer, NM; Swi, AIA; Wheeler, AA | 1 |
| Wang, D; Xu, J; Yang, J; Zhang, M | 1 |
| Fu, R; Hu, Y; Kang, X; Li, Y; Shan, W; Sun, R; Tian, X; Wang, R; Wang, Z; Yao, J; Zhao, Y; Zhou, J | 1 |
| Hu, Y; Li, H; Li, X; Sun, X; Wang, T; Xu, L; Yang, X; Yu, S; Zhao, B | 1 |
4 other study(ies) available for coenzyme a and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD.
Topics: Biomarkers; Carbon Dioxide; Coenzyme A; Fatty Acids; Humans; Inflammation; Liver; Mitochondrial Turnover; Non-alcoholic Fatty Liver Disease; Obesity; Oxidoreductases; Reactive Oxygen Species | 2022 |
Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation.
Topics: AMP-Activated Protein Kinases; Animals; Coenzyme A; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Mice; Non-alcoholic Fatty Liver Disease; Osteocalcin; Palmitic Acid; Stearoyl-CoA Desaturase | 2023 |
Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease.
Topics: Animals; Coenzyme A; Diet, High-Fat; Hydroxybenzoates; Ligases; Liver; Mice; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Rats; Sirtuin 3 | 2020 |
miR-23b Ameliorates nonalcoholic steatohepatitis by targeting Acyl-CoA thioesterases 4.
Topics: Animals; Coenzyme A; Disease Models, Animal; Hepatocytes; Lipid Metabolism; Liver; Liver Cirrhosis; Male; Mice, Inbred C57BL; MicroRNAs; Non-alcoholic Fatty Liver Disease; Triglycerides | 2021 |